- Home
- IKT vs CCRD Comparison
IKT vs CCRD Comparison
Compare IKT & CCRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKT
- CCRD
- Stock Information
- Founded
- IKT 2008
- CCRD 1973
- Country
- IKT United States
- CCRD United States
- Employees
- IKT N/A
- CCRD N/A
- Industry
- IKT Biotechnology: Pharmaceutical Preparations
- CCRD
- Sector
- IKT Health Care
- CCRD
- Exchange
- IKT Nasdaq
- CCRD Nasdaq
- Market Cap
- IKT 168.0M
- CCRD 157.9M
- IPO Year
- IKT 2020
- CCRD N/A
- Fundamental
- Price
- IKT $2.00
- CCRD $20.55
- Analyst Decision
- IKT Buy
- CCRD Hold
- Analyst Count
- IKT 2
- CCRD 1
- Target Price
- IKT $8.00
- CCRD $21.00
- AVG Volume (30 Days)
- IKT 113.6K
- CCRD 16.4K
- Earning Date
- IKT 05-14-2025
- CCRD 05-08-2025
- Dividend Yield
- IKT N/A
- CCRD N/A
- EPS Growth
- IKT N/A
- CCRD 187.14
- EPS
- IKT N/A
- CCRD 0.86
- Revenue
- IKT N/A
- CCRD $61,011,000.00
- Revenue This Year
- IKT N/A
- CCRD $9.82
- Revenue Next Year
- IKT N/A
- CCRD N/A
- P/E Ratio
- IKT N/A
- CCRD $23.22
- Revenue Growth
- IKT N/A
- CCRD 12.31
- 52 Week Low
- IKT $1.12
- CCRD $11.57
- 52 Week High
- IKT $4.20
- CCRD $24.97
- Technical
- Relative Strength Index (RSI)
- IKT 46.57
- CCRD 57.31
- Support Level
- IKT $1.78
- CCRD $16.84
- Resistance Level
- IKT $2.13
- CCRD $20.30
- Average True Range (ATR)
- IKT 0.16
- CCRD 1.19
- MACD
- IKT -0.01
- CCRD 0.08
- Stochastic Oscillator
- IKT 37.61
- CCRD 72.50
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
About CCRD CoreCard Corporation
CoreCard Corp is engaged in the business of providing technology solutions and processing services to the financial technology and services market. It designs, develops and markets a comprehensive suite of software solutions to program managers, accounts receivable businesses, financial institutions, retailers and processors to manage their credit and debit cards, prepaid cards, private label cards, fleet cards, buy now pay later programs, loyalty programs and accounts receivable and loan transactions. The CoreCard software platform and modules include CoreENGINE, CoreISSUE, CoreFRAUD, CoreCOLLECT, CoreAPP, CoreMONEY and CoreACQUIRE. Its customers are located in the U.S, European Union and the Middle East of which key revenue is derived from the U.S.